Temporal trends in pulmonary arterial hypertension: Results from the COMPERA registry

CONCLUSIONS: The use of combination therapy increased from 2010 to 2019, but most patients still received monotherapy. Survival rates at 1 year after diagnosis did not change over time. Future studies need to determine if the observed trend suggesting improved 3-year survival rates can be confirmed.PMID:34675047 | DOI:10.1183/13993003.02024-2021

Source: Respiratory Care - October 22, 2021 Category: Respiratory Medicine Authors: Marius M Hoeper Christine Pausch Ekkehard Gr ünig Gerd Staehler Doerte Huscher David Pittrow Karen M Olsson Carmine Dario Vizza Henning Gall Oliver Distler Christian Opitz J Simon R Gibbs Marion Delcroix H Ardeschir Ghofrani Stephan Rosenkranz Da-Hee Par Source Type: research